Literature DB >> 4617340

Molecular approaches for designing antiviral and antitumor compounds.

P Chandra.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4617340     DOI： 10.1007/3-540-06873-2_15

Source DB:  PubMed          Journal:  Top Curr Chem        ISSN： 0340-1022


× No keyword cloud information.
  5 in total

1.  Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli.

Authors:  N Tanese; J Sodroski; W A Haseltine; S P Goff
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

2.  Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.

Authors:  V R Prasad; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Elimination of resistance determinants from R-factor R1 by intercalative compounds.

Authors:  F E Hahn; J Ciak
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

4.  Induction of cytokines by tilorone hydrochloride.

Authors:  W Zschiesche; B Fahlbusch; I Schumann; E Tonew
Journal:  Agents Actions       Date:  1978-10

5.  Euphornin reduces proliferation of human cervical adenocarcinoma HeLa cells through induction of apoptosis and G2/M cell cycle arrest.

Authors:  Xiao-Qiang Li; Yin-Liang Bai; De-Li Zhang; Hai-Sheng Jiao; Rong-Xia He
Journal:  Onco Targets Ther       Date:  2018-07-27       Impact factor: 4.147
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.